Market Currents
Orexigen (OREX +17%) is another benificiary of Arena's (ARNA) good fortune today. Contrave is an...
-
Wednesday, June 27, 2012, 2:30 PM ETOrexigen (OREX +17%) is another benificiary of Arena's (ARNA) good fortune today. Contrave is an investigational medication OREX has been working on that also focuses on the treatment of obesity, however it's still in the developmental stages.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
